ValorQ4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26TTMGastos comerciales, generales y administrativos158.85 M157.23 M159.39 M152.77 M155.81 M154.57 M622.54 MInvestigación y desarrollo22.36 M23.29 M21.87 M21.25 M21.09 M21.28 M85.48 MBeneficio operativo37.69 M12.89 M10.59 M13.72 M5.63 M13.58 M43.52 MTotal de ingresos no operativos-6.02 M-1.76 M1.82 M607 K-894 K-1.06 M471 KGastos por intereses, netos de intereses capitalizados34.24 M22.03 M20.55 M19.81 M30.95 M16.49 M87.8 MIngresos no operativos, una vez deducidos los gastos por intereses-40.26 M-23.79 M-18.73 M-19.2 M-31.84 M-17.55 M-87.33 MIngresos/gastos extraordinarios———————Beneficio antes de impuestos-66.01 M-10.91 M33.68 M-2.51 M1.87 M-3.98 M29.06 MParticipación en los beneficios002.84 M-1.54 M-2.48 M-607 K-1.8 MImpuestos32.05 M4.57 M1.18 M-658 K-2.65 M-34.71 M-36.85 MParticipación minoritaria———————Otros ingresos/gastos después de impuestos—-557 K1.18 M-10.18 M—-2.99 M—Beneficio neto antes de actividades interrumpidas-23.83 M-15.48 M35.34 M-3.4 M-15.73 M30.13 M46.34 MOperaciones suspendidas———————Beneficio neto-23.83 M-15.48 M35.34 M-3.4 M-15.73 M30.13 M46.34 MAjuste por dilución———————Dividendos de las acciones preferentes———————Beneficio neto diluido atribuible a los accionistas-23.83 M-15.48 M35.34 M-3.4 M-15.73 M30.13 M46.34 MBeneficio básico por acción-0.97-0.631.43-0.14-0.631.221.88Beneficio por acción diluido-0.97-0.631.43-0.14-0.631.21.86Número medio de acciones ordinarias24.39 M24.54 M24.64 M24.69 M24.64 M24.76 M—Acciones diluidas24.39 M24.54 M24.71 M24.69 M24.9 M25.18 M—EBITDA475.73 M62.33 M60.25 M64.52 M376.88 M63.61 M565.26 MEBIT422.84 M12.89 M10.59 M13.72 M326.05 M13.58 M363.94 MCosto de los ingresos17.4 M394.59 M340.8 M336.11 M17.3 M324 M1.02 BOtros costes de producción———————Amortización y depreciación (flujo de caja)52.99 M49.45 M49.66 M50.8 M50.83 M50.03 M201.32 M
ICU Medical, Inc. - Common Stock
ICU Medical, Inc. is a medical technology company based in San Clemente, California. ICU Medical products are designed to prevent bloodstream infections and protect healthcare workers from exposure to infectious diseases or hazardous drugs. ICU Medical product line includes intravenous therapy (IV) products, pumps, needle-free vascular access devices, custom infusion sets, closed system hazardous drug handling devices and systems, sensor catheters, needle-free closed blood sampling systems, and hemodynamic monitoring systems.
ICU Medical products are designed to prevent bloodstream infections and protecting healthcare workers from exposure to infectious diseases or hazardous drugs. In addition, the company's IV medication compounding and delivery products are designed to improve medication and dosing accuracy and improve clinical workflows. In 2014 ICU Medical was named one of the 100 Most Trustworthy Companies in America by Forbes Magazine.